High-throughput Sequencing (HTS)-Based Diagnosis of Geminiviruses.

Methods Mol Biol

Dep. de Fitopatologia/BIOAGRO, Universidade Federal de Viçosa, Viçosa, MG, Brazil.

Published: March 2025

The development of high-throughput sequencing (HTS) technologies has revolutionized plant virology. One of the many application of HTS is the detection and diagnostics of plant viruses. The main advantage of HTS compared to other diagnostics methods is its unbiased nature, meaning that it is capable of detecting any virus present in the sample. Thus, it is particularly suitable for the discovery of new viruses. This chapter provides a step-by-step guide on how geminivirus diagnosis is performed using short-read HTS.

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-0716-4454-6_15DOI Listing

Publication Analysis

Top Keywords

high-throughput sequencing
8
sequencing hts-based
4
hts-based diagnosis
4
diagnosis geminiviruses
4
geminiviruses development
4
development high-throughput
4
hts
4
sequencing hts
4
hts technologies
4
technologies revolutionized
4

Similar Publications

DNAcycP2: improved estimation of intrinsic DNA cyclizability through data augmentation.

Nucleic Acids Res

February 2025

Department of Statistics and Data Science, Northwestern University, 633 Clark Street, Evanston, IL 60208, United States.

Loop-seq is a pioneering high-throughput assay that enables the simultaneous quantification of intrinsic cyclizability across a large set of DNA fragments. However, the assay's reliance on biotin-tethered elongated DNA fragments introduces a tethering effect, leading to biased cyclizability measurements. We demonstrate that the current de-biasing technique is inadequate for fully mitigating this bias.

View Article and Find Full Text PDF

Characterisation of the Novel HLA-A*02:1178 Allele Using Next-Generation Sequencing Methods.

HLA

March 2025

Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China.

The HLA-A*02:1178 allele differs from HLA-A*02:07:01:01 by one nucleotide substitution in codon 326 in exon 7.

View Article and Find Full Text PDF

HLA-DRB5*01:02:05 differs from the HLA-DRB5*01:02:01 by one synonymous nucleotide in codon 14 in exon 2.

View Article and Find Full Text PDF

Identification of the Novel HLA-A*11:481 Allele by Next-Generation Sequencing.

HLA

March 2025

Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China.

The HLA-A*11:481 allele differs from HLA-A*11:01:01:01 by one nucleotide substitution in codon -8 in exon 1.

View Article and Find Full Text PDF

HLA-B*27:284 differs from HLA-B*27:07:01 by one nucleotide substitution in exon 4, at gDNA position 1614 (G>A).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!